Annals of Family Medicine
NOVEMBER 20, 2024
However, facing the challenges brought by China's national health strategy, aging population, and high incidence of chronic diseases, there is an urgent need to improve the service capacity of China's primary medical institutions.
The Health Policy Exchange
FEBRUARY 20, 2014
Mobile health, or "mHealth" for short, describes technology that allows clinicians or public health professionals to monitor and/or deliver health-related messages to patients via cellular phones, tablets, or other wireless devices. electrocardiogram) and would pose safety risks to patients if they malfunctioned.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Physicians Foundation
FEBRUARY 14, 2025
Scorecard with National and State Level Data Reveals Workforce Shortages, Low Primary Care Reimbursement, and Reduced Patient Access to Vital Services February 18, 2025 – As the nation faces a widespread surge in chronic diseases, the third Primary Care Scorecard highlights how systemic disinvestment in U.S.
Physician's Weekly
JUNE 26, 2025
This starts with recognition that obesity is a chronic disease. When a child has risk factors but has not developed the disease, we must continue to provide preventive care and support for the family and appropriately match intensity and dose of the intervention. What modifications would you recommend to clinicians?
My Green Doctor
APRIL 4, 2025
In This Issue : New Research: Teaching Patients about Climate Resilience Make the Pledge Today to Go Green Get Ready for Earth Day 2025 (part 2)! It tells your office colleagues and patients that your healthcare practice or clinic is committed to forging a healthier work space and community. The healthcare sector contributes 8.5%
GeriPal
JULY 19, 2024
What hasn’t been shown, Eric, is that if you apply tools like this, clinical outcomes down the road are better for patients. I don’t have access to change the levers of government. They’re dedicated, committed, they’re there for their patients and they understand it’s really important.
FDA Law Blog
JANUARY 12, 2025
Whether a surrogate or intermediate clinical endpoint (ICE), the endpoint to support accelerated approval is one that can be assessed more rapidly than the ultimate clinical benefit; this is what enables earlier patient access than would be possible while generating the evidence to support a traditional approval, which is typically infeasible.
Expert insights. Personalized for you.
130 
Let's personalize your content